Galderma shares new interim analysis data from trial for prurigo nodularis
Galderma has reported new interim analysis data from the OLYMPIA long-term extension trial of monoclonal antibody Nemluvio for the treatment …
Post
-
-
Transgene completes initial screening in Phase II part of TG4050 vaccine trial
Transgene has completed the initial subject screening for the Phase II segment of its Phase I/II trial of individualised neoantigen …
-
Japan offers competitive edge with clinical trial landscape and SMO approach
“Japan has the second biggest market for branded drugs and is the third largest market for pharmaceuticals overall,” says Kento …
-
Developing resilient strategies to overcome challenges in clinical research in Europe
At the 15th Annual Outsourcing in Clinical Trials (OCT) Europe conference, which took place between 29 and 30 April in …
-
Enrolment concludes in Phase III trial of Dizal’s sunvozertinib for NSCLC
Dizal has completed subject enrolment for the randomised Phase III WU-KONG28 trial of oral sunvozertinib for treating non-small cell lung …
-
AbbVie’s Phase III trial of atogepant for migraine meets primary goal
AbbVie has announced that its Phase III TEMPLE study, which compared the oral calcitonin gene-related peptide (CGRP) receptor antagonist, atogepant, …
-
BioOrbit eyes 2026 for pre-clinical trials of space manufactured protein crystals
BioOrbit aims to kick off pre-clinical trials to study protein crystals for monoclonal antibodies (mAbs) produced in a pharmaceutical factory …
-
Biogen starts dosing in Phase III trial of Friedreich ataxia therapy
Biogen has commenced dosing in the Phase III BRAVE study to assess omaveloxolone in children of two to less than …
-
New study investigates autism spectrum disorder prevalence
Autism spectrum disorder (ASD) is a neurodevelopmental disorder that includes a variety of differences or challenges with social communication and …
-
MSD and Daiichi announce first subject dosing in prostate cancer trial
MSD and Daiichi Sankyo have announced first subject dosing in the randomised IDeate-Prostate01 Phase III trial of ifinatamab deruxtecan (I-DXd) …
-
NHS England chair suggests England can learn from European health schemes
With the 10-year Health Plan on the horizon, the NHS could learn some tricks from France, Germany and the Nordics. At …
-
Skyhawk begins dosing in Huntington’s disease trial of SKY-0515
Skyhawk Therapeutics has dosed the first subject in the randomised Phase II/III FALCON-HD trial of the oral small-molecule RNA splicing …
-
FDA Commissioner envisions fewer delays, more clinical trial flexibility and AI use
US Food and Drug Administration (FDA) Commissioner Dr. Marty Makary addressed concerns about the recent cuts impacting the agency’s ability …
-
Ensuring success in oncology clinical trials
Oncology clinical trials are complex and costly, making a successful setup critical. Facing challenges such as long timelines and patient …
-
Lyell reports new clinical data from trial of large B-cell lymphoma therapy
Lyell Immunopharma has reported new clinical data from the Phase I/II clinical trial of autologous dual-targeting CD19/CD20 chimeric antigen receptor …
